THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q1 2022
Shares 200,000 Value ($000) $190 Avg Close — Range —
Q4 2021
Shares 200,000 Value ($000) $193 Avg Close — Range —
Q3 2021
Shares 200,000 Value ($000) $185 Avg Close — Range —
Q2 2021
Shares 1,300,000 Value ($000) $1,243 Avg Close — Range —
Q1 2021
Shares 1,300,000 Value ($000) $1,329 Avg Close — Range —
Q4 2020
Shares 1,300,000 Value ($000) $1,231 Avg Close — Range —
Q3 2020
Shares 1,300,000 Value ($000) $1,169 Avg Close — Range —
Q2 2020
Shares 1,300,000 Value ($000) $1,254 Avg Close — Range —
Q1 2020
Shares 1,300,000 Value ($000) $1,255 Avg Close — Range —
Q4 2019
Shares 1,000,000 Value ($000) $962 Avg Close — Range —
Q3 2019
Shares 1,000,000 Value ($000) $924 Avg Close — Range —